07-21-2006: Pall Corporation announced the election of Dennis Longstreet to the Company's Board of Directors on July 18, 2006. Mr. Longstreet will be a nominee for re-election on the Company's proxy for the annual meeting of shareholders in November.
Mr. Longstreet, 60, was a Company Group Chairman for Johnson & Johnson's Medical Devices from 1998 until his retirement in late 2005, culminating a 36-year career with Johnson & Johnson in increasingly senior operational and sales management roles. During his tenure as Company Group Chairman, Mr. Longstreet oversaw several major acquisitions and technology licenses, re-energized the global Ethicon business, and delivered five consecutive years of double-digit sales and income growth for J&J Medical Devices and Diagnostics in Latin America. He served as a member of the J&J Medical Device & Diagnostics Operating Committee from 1998 to 2005 and as Worldwide Franchise Chairman of the Ethicon Endo-Surgery and Indigo business from 1998 to 2000.
Prior to that, Mr. Longstreet was Chairman of the Johnson & Johnson Health Care Systems, Inc. (1995 - 1998), a major supplier of J&J services and products to US managed healthcare companies and hospitals. Previously, he was the founding President of Ortho Biotech Inc. (1986 - 1995), developing and implementing the strategy to move J&J into the biotechnology pharmaceutical business. Prior to that, he served as Vice President, Corporate Development for Ortho Pharmaceutical Corporation after progressing through several sales management roles of increasing responsibility. Mr. Longstreet began his J&J career as a Sales Representative in 1969.
Mr. Longstreet is Chairman of the AdvaMed Industry Foundation and the past Chairman of the AdvaMed Industry Association Board (2002 - 2004). He is a member of the Board of Trustees of Rider University and Board of Governors of Muhlenberg Regional Medical Center, Plainfield, New Jersey. He holds a BS degree in Marketing from Rider University.
Watchlist
This is where you can add this news to your personal favourites
Pall Corporation announced the election of Dennis Longstreet to the Company's Board of Directors on July 18, 2006. Mr. Longstreet will be a nominee for re-election on the Company's proxy for the annual meeting of shareholders in November.
Mr. Longstreet, 60, was a Company Group Chairman fo ... more
Pall Corporation and zeta Holding GmbH announced that they have entered into an agreement to collaborate in the use of specific automation software and development, supply and marketing of equipment packages for fermentation, recovery and purification of biotech products.
Under the terms ... more
Pall Corporation announced that is has acquired Euroflow (UK). The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography ... more
Porous filter ceramics manufactured by Pall Schumacher, used in world-wide applications for the filtration of gases and liquids. Our quality standards are valued and demanded by our customers. more
Pall Corporation is the largest and most diverse filtration, separations and purifications company in the world. Our technical expertise, product portfolio and global reach are unmatched. This diversity is a considerable strength. It enables us to leverage opportunities across industries an ... more
The life sciences industry is both driven and united by its need for speed to market, product reliability and economics. Pall’s leading edge filtration, separation and purification technologies and services play an essential and pivotal role in this industry’s ability to achieve these goals ... more